Akeso, Inc. — Chinese biopharma developing antibody-based cancer immunotherapies.
| Exchange | Symbol | Mark | Index | Basis | FundingEach venue's rate is converted to an hourly equivalent. Annualized funding = hourly rate × 24 × 365 (not compounded). Multi-venue values are weighted by 24h volume. | Volume 24h | Vol % | OI (USD) | Live |
|---|---|---|---|---|---|---|---|---|---|
![]() | AKESO_USDT | 12.61 | 12.74 | -100.0 bps | --:--:--+0.0100%(+10.95% ann) | $2.3K | 100.0% | $29.77K | 121d |